CD38 and COVID-19: By further elucidating the function of the CD38-NAD+ metabolic axis in immune metabolism and signaling, we can explore novel therapeutic strategies to modulate immune responses, enhance anti-infective capabilities, and potentially offer new avenues for treating COVID-19 and other diseases.